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LETTER TO THE EDITOR

Vitamin D in COVID-19 Pneumonia: High Yield with Low
Risk
Sir,
The novel coronavirus disease 2019 (COVID-19) is a global
public health problem with particularly poor outcomes in the
elderly. The disease pathogenesis and presentation is still
evolving. Vitamin D is a fat-soluble, secosterol that exists in two
forms: vitamin D2 and D3. It is obtained mostly from food with a
small portion synthesised by sunlight. The association of low
vitamin D levels with increased susceptibility to upper respiratory tract infections (URTIs) is known in the literature.1 A meta-analysis did show beneﬁt of taking vitamin D supplementation
among patients with low 25 hydroxy-vitamin D levels
presenting with URTIs.3,4 There are studies suggesting utility of
vitamin D both in prevention, and in decreasing severity and
mortality among patients with COVID-19 pneumonia. The mechanism is linked to development of antimicrobial peptides and
activation of dendritic cells, macrophages, T and B lymphocytes
through utilisation of vitamin D receptors (VDR) that improve
immunity and decrease inﬂammatory response against
COVID-19.4,5 The virus interacts with ACE2 receptors on type II
pneumocytes and leads to cell death. Vitamin D also has
immunomodulatory properties that downregulate activity of
pro-inﬂammatory cytokines and further suppress ACE2
receptor activity.4,5 This protective eﬀect of vitamin D can be
achieved by a single oral vitamin D3 dose (2000 IU).
The COVID-19 disease severity may be linked to location of countries, which in turn, determines the extent of sunlight exposure.
In this regard, it is reported that dermal production of vitamin D
from solar UVB between October to March is low above 35
degrees latitude. Countries included in these regions are
predominantly inhabited by elderly, who are predisposed to
higher probability of cardio-pulmonary and metabolic comorbidities. This might be a reason for such high incidence and
mortality from COVID-19 in Western Europe and America. The
cross-sectional analysis of 20 European countries does prove
the notion that majority of people who suﬀered death were
elderly and likely vitamin D deﬁcient, based on data analysis
from those regions. The problem is exacerbated during
prolonged lockdown, where people are not getting enough
sunlight exposure and; hence, stressed on already deﬁcient
vitamin D levels.
Vitamin D can be used as supplementary therapy in patients to
boost up the innate immunity and to combat mild to moderate
COVID-19 pneumonia. Micronutrient supplementation
including vitamin D and C should be started early in the disease
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process. Though vitamin D utility in COVID-19-related pneumonia has not been evaluated, trials are underway to further
test its eﬃcacy in COVID-19-associated pneumonia; and the
results are expected in the coming months. The current treatments in use are very expensive and need validation through
superiority designs. Early administration of vitamin D may
prove beneﬁcial in reducing the severity of symptoms and
possibly hospitalisation rates in low resource settings like
Pakistan.
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